Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein R1 (FOXR1) is a member of the forkhead box (FOX) family of transcription factors, which are highly conserved, monomeric proteins characterized by a helix-turn-helix DNA-binding domain known as the forkhead box or \"winged-helix\" domain[1][2][3][6]. FOXR1 acts as both a transcriptional activator and repressor, regulating the expression of genes involved in the cellular stress response, such as heat shock proteins (HSPA1A, HSPA6) and antioxidant enzymes (DHRS2), which are important in protecting cells against oxidative stress[1][2]. FOXR1 has low but broad expression—most prominent in the brain and reproductive organs—across development and into adulthood[1][2][4]. Experimental deletion of Foxr1 in mice leads to reduced survival, abnormal brain development (including thinning of the cortex and enlarged ventricles), and decreased body weight at birth, indicating a critical role in normal brain development and possibly cell survival[1]. Rare human mutations in FOXR1 have been implicated in neurological disorders characterized by microcephaly, progressive brain atrophy, and global developmental delay[1]. FOXR1 is also found within a chromosomal region often deleted in neuroblastomas, and mutations have been reported in several carcinomas, but its role in cancer and as a direct therapeutic target has not been established[2][1]. There are currently no known drugs that specifically interact with FOXR1, and it is not considered a canonical therapeutic target such as an enzyme, receptor, or transporter.\n\nFOXR1 is a stress-responsive transcription factor with key roles in protein folding and brain development[1][2][6]. Pathogenic FOXR1 mutations cause protein misfolding and impaired stress response, leading to neurodevelopmental pathology[1]. While associated with cancer and neurological disorders, FOXR1 is not a validated drug target and has no known pharmacological modulators[1][2]. Common aliases are FOXR1, FOXN5, DLNB13, forkhead box protein N5, and forkhead box protein R1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein R1 (FOXR1).